If the LV is likely to improve or normalize with TAVI, there’s no reason not to treat, says Guy Witberg. But for some TAVI ...

As a slew of new catheter-based devices hit the market, it will be crucial to keep tabs on eligibility, safety, and access, ...

For women—but not men—who are part of the LGBTQ+ community, the overall CV health impact posed by being a sexual minority ...

Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.

Physicians forced to make rapid-fire choices, with limited evidence, in acute myocardial infarction complicated by ...

LONG BEACH, CA—The long-held practice of requiring patients to fast prior to cardiac catheterization is again being ...

All but one of our top stories this month stemmed from ACC 2024, but not all were from the main tent sessions.

Following the US approval of the Agent paclitaxel-coated balloon for the treatment of in-stent restenosis (ISR), the first coronary procedures with the device were performed Tuesday morning at two ...

The Society of Thoracic Surgeons (STS) has published three new online calculators that spell out personalized risks for ...

The approval marks the return of the dissolving-scaffold concept, which so far has failed to find success in the coronaries.

There needs to be a “focus on prevention of diseases and a redesign of how we deliver care,” says Marat Fudim.

The algorithm can identify noncoronary signals, offering insights into ventricular function and cardiac index, investigators say.